ARTICLE | Clinical News
Celgene regulatory update
October 16, 1995 7:00 AM UTC
The FDA approved a request from the Warren, N.J., company to recover costs of providing its experimental thalidomide drug, Synovir, to treat cachexia in AIDS patients. The product costs $550 for a 12...